Showing results (121-130 of 140) with videos related to
Sort By:
Pageof 14
European Journal of Haematology. Supplementum|July 13, 2005
Current treatment strategies of the German Hodgkin Study Group (GHSG)Beate Klimm, Volker Diehl, Beate Pfistner, et al.European Journal of Haematology. Supplementum|July 13, 2005
The role of allogeneic stem-cell transplantation in Hodgkin's diseaseN Schmitz, A SuredaEuropean Journal of Haematology. Supplementum|July 13, 2005
Developing new drugs for the treatment of lymphomaOwen A O'ConnorEuropean Journal of Haematology. Supplementum|February 10, 2009
Immune thrombocytopenic purpura: epidemiology and implications for patientsMarc MichelEuropean Journal of Haematology. Supplementum|February 10, 2009
Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpuraAdrian NewlandEuropean Journal of Haematology. Supplementum|June 18, 2010
Meeting the unmet needs in anticoagulant therapyJeffrey I WeitzEuropean Journal of Haematology. Supplementum|January 1, 1996
When should the clinician suspect a drug-induced blood dyscrasia, and how should he proceed?H HeimpelEuropean Journal of Haematology. Supplementum|January 1, 1996
Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation GroupA BacigalupoEuropean Journal of Haematology. Supplementum|January 1, 1996
Incidence and non-drug aetiologies of aplastic anaemia in Thailand. The Thai Aplastic Anaemia Study GroupS Issaragrisil, D W Kaufman, T AndersonEuropean Journal of Haematology. Supplementum|January 1, 1996
Drug use and aplastic anaemia: the French experience. French Cooperative Group for the Epidemiological Study of Aplastic AnaemiaJ Y Mary, M Guiguet, E BaumelouPageof 14